Mind Medicine (MindMed) Inc. is a listed company. Its insiders report their share dealings to SEDI. Over the twelve months to 24 October 2026, 1 filing were filed, from 1 insider.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
There has been no open-market purchase by an insider of Mind Medicine (MindMed) Inc. for at least a year.
With 1 filing in twelve months, the company is quieter than the median of 13 filings across the 2,472 companies we follow on the same exchange. Over the whole record (from 2022), the tally stands at no purchases and 8 sales.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 43 declarations
Mind Medicine (MindMed) Inc. is a biopharmaceutical company focused on developing psychedelic-inspired therapies for mental health disorders. It is listed on the Toronto Stock Exchange under the symbol MMED.